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The reader will be able to
 Appreciate that left vocal cord paresis (LVCP) is a significant side-effect of surgical closure of PDA in neonates born preterm.
 Appreciate the clinical importance of performing postoperative laryngoscopy in all infants born preterm exposed to surgical closure
of PDA.
 Understand that LVCP can present with a wide variety of clinical symptoms in the neonatal period and later in life.
 Understand the risks of misdiagnosing LVCP.a r t i c l e i n f oKeywords:




Laryngoscopya b s t r a c t
Context: Extremely premature (EP) infants are at increased risk of left vocal cord paralysis (LVCP) follow-
ing surgery for patent ductus arteriosus (PDA).
Objective: A Systematical Review was conducted to investigate the incidence and outcomes of LVCP after
PDA ligation in EP born infants.
Data sources: Searches were performed in Cochrane, Medline, Embase, Cinahl and PsycInfo.
Study selection: Studies describing EP infants undergoing PDA surgery and reporting incidence of LVCP
were included.
Data extraction and synthesis: Study details, demographics, incidence of LVCP, diagnostic method and
reported outcomes were extracted. DerSimonian and Laird random effect models with inverse variance
weighting were used for all analyses.
Study appraisal: The Newcastle-Ottawa scale for observational studies was used for quality assessment.
Results: 21 publications including 2067 infants were studied. The overall pooled summary estimate of
LVCP incidence was 9.0% (95% CI 5.0, 15.0). However, the pooled incidence increased to 32% when only
infants examined with laryngoscopy were included. The overall risk ratio for negative outcomes was
higher in the LVCP group (2.20, 95% CI 1.69, 2.88, p = 0.01) compared to the non-LVCP-group.
Conclusions: Reported incidence of LVCP varies widely. This may be explained by differences in study
designs and lack of routine vocal cords postoperative assessment. LVCP is associated with negative out-
comes in EP infants. The understanding of long-term outcomes is scarce. Routine laryngoscopy may be
necessary to identify all cases of LVCP, and to provide correct handling for infants with LVCP.
 2017 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).nal age;
M.S. Engeseth et al. / Paediatric Respiratory Reviews 27 (2018) 74–85 75Introduction and the Cochrane Library. The search was updated on DecemberThe ductus arteriosus fails to close spontaneously in up to 40–
65% of extremely premature infants [1,2]. A patent ductus arterio-
sus (PDA) shunts blood back from the descending aorta into the
pulmonary artery, potentially causing systemic hypoperfusion
and pulmonary over circulation [3].
PDA surgical ligation is currently the second-line of treatment,
and it is used when the medical treatment has failed or is
contra-indicated [4,5]. Up to 20–30% of extremely premature
infants with a clinically significant PDA undergo surgical PDA liga-
tion [1,6,7]. This can be done by applying a small metal clip or by
using a suture. Because of its close proximity to the ductus arterio-
sus [8], the left recurrent laryngeal nerve may be injured during
surgery, causing both left vocal cord paresis or paralysis (LVCP).
Early symptoms of LVCP are stridor, hoarseness, weak cry and
feeding difficulties [9,10]. However, symptoms can be weak or
even absent. In fact, LVCP can be unnoticed unless specifically
looked for postoperatively for example via [11] flexible nasolaryn-
goscopy. This procedure allows visualization of the larynx without
the use of anaestetics [12] and is the recommended diagnostic
method for LVCP in infants [13,14]. Known risk factors for LVCP
after surgical PDA ligation are low gestational age at birth (GA)
[11], low birth weight (BW) [15] and low weight at surgery
[11,16]. Thus, extremely premature infants undergoing surgical
PDA ligation have an increased risk of iatrogenic nerve damage
compared to other premature infants [17]. A recent metaanalysis
reported large discrepancies between studies regarding the inci-
dence of LVCP in infants and children undergoing cardiothoracic
surgery for congenital heart disease [16]. Some of this variability
could potentially be explained by inconsistencies regarding post-
operative vocal cord evaluation between studies [16].
The objectives of this study are to (1) determine the incidence
of LVCP after surgical PDA ligation in extremely premature infants,
(2) determine study level characteristics that may explain the wide
incidence variation reported by different studies and (3) explore
short- and long-term consequences and/or associated co-
morbidities of LVCP in extremely premature born infants.
Methods
Protocol and registration
We registered the review protocol in the PROSPERO Interna-
tional prospective register of systematic reviews under the identi-
fication number CRD42016029921 (Supplemental File 1) and
followed the checklist for Preferred Reporting Items for Systematic
Reviews and Meta analyses (PRISMA, Supplemental File 2) [18].
Eligibility criteria
We included studies of extremely premature infants born at
gestational age 28 weeks and/or 1000 g birthweight diagnosed
with PDA, and reported cases of LVCP following surgical PDA liga-
tion. We excluded studies with less than 80% of extremely prema-
ture infants or lacking a description of a subpopulation of
extremely premature infants. Eligible study designs were cohort
or case-control. Case reports, case series, narrative reviews, letters,
editorials, commentaries and abstracts were excluded. Outlined in
Supplemental File 3.
Literature search strategy
We searched the following databases from their inception
through December 19, 2015: MEDLINE, Embase, PsycINFO, Cinahl20th, 2016 without additional included citations. In collaboration
with a librarian (G.A), M.S.E. developed a highly sensitive search
strategy for MEDLINE, using search terms relevant to the popula-
tion and intervention (e.g., extremely premature infants, patent
ductus arteriosus ligation). To identify grey literature, we searched
Open Grey and Google Scholar. We searched Prospero and Clinical
trials.gov for ongoing studies, and reference lists of relevant
reviews and citations of included studies to identify other poten-
tially relevant references. The search strategy was modified for
the other databases. No restrictions were placed on publication
date, study design or language. We describe the complete search
strategy in Supplemental File 4.
Study selection
Two investigators (M.S.E. and S.M.) independently conducted
the initial screening of references identified by the search strategy.
Titles and abstracts were retained for full-text review if one of the
investigators identified the study as being potentially eligible. Two
investigators (M.S.E. and O.D.R.) independently screened the
remaining full text references. Any disagreements were resolved
by consensus, and a third investigator (S.M.) was consulted if con-
sensus was not met.
Data abstraction
One investigator (M.S.E.) abstracted data from the selected
studies, while another investigator (O.D.R.) over-read the
abstracted data for inconsistencies. Disagreements regarding data
abstracted were resolved by consensus between the two authors.
The following data were extracted: Author details, year of publica-
tion, study methods, key characteristics of participants, interven-
tion details, control conditions, incidence LVCP, diagnostic
method and outcomes.
In addition, study authors were contacted for additional infor-
mation if needed. They were asked about full text versions of
abstracts, assessment method for LVCP, or information about num-
ber of extremely premature infants in the cohort, potentially
allowing us to perform sub-analysis of incidence of LVCP in
extremely premature infants.
Quality assessment of individual studies
Two investigators (M.S.E. and N.R.O.) independently assessed
methodological quality of identified studies using the Newcastle-
Ottawa Quality Assessment Scale (NOS) [19]. This is a quality mea-
sure tool for observational studies recommended by Cochrane [20]
that assesses methodological quality by assigning points up to a
maximum of nine points for the least risk of bias in three domains:
(1) selection of study groups (four points); (2) comparability of
groups (two points); and (3) ascertainment of exposure and out-
comes (three points). We provide further details on the use of
NOS for this Systematic Review in Supplemental File 5. Disagree-
ments were resolved by consensus or through a third investigator
(O.D.R).
Synthesis of results
We statistically pooled results when 2 studies were present
for the same outcome. A pooled proportion of the incidence of
LVCP including 95% confidence intervals (CIs) was calculated. Inci-
dence was calculated by dividing the number of reported cases of
LVCP by the total number of PDA ligated infants in each study, not
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DerSimonian and Laird random effect model with inverse variance
weighting was used for all analyses. A Freeman–Tukey Double Arc-
sine Transformation was used to stabilize the variances prior to
pooling for incidence estimates. For the analysis of and/or associ-
ated co-morbidities, we pooled studies using random effects mod-
els estimating risk ratios and 95% confidence intervals. Due to the
small number of studies reporting consequences and/or associated
co-morbidities, we did not attempt to stratify when significant
heterogeneity was present. Heterogeneity between studies was
tested for both incidence proportion and consequences with
Cochrane’s Q and I-squared. High heterogeneity was indicated by
a Q p-value <0.10 or I-squared >50%. When substantial heterogene-
ity was present, we attempted to explain heterogeneity by stratify-
ing by a priori covariates. Publication bias was assessed by visual
inspection of the funnel plot and an Egger’s test for the main anal-
ysis of occurrence of LVCP. All analyses were conducted using Stata
14.0 (College Station, TX).
Results were synthesized descriptively if a quantitative synthe-
sis was not feasible. We placed greater emphasis on the evidence
coming from studies with more precise estimates of effect. We also
focused on documenting and identifying patterns of the interven-
tion across outcome categories. We analyzed potential reasons
for inconsistencies in treatment effects across studies by evaluat-
ing differences in method of assessment, intervention and study
design.Results
Study selection
The literature search identified 1985 unique records. Many of
these (1815 or 91.4%) were excluded by title and abstract screen.
In addition, we were not able to retrieve the full texts of 37
abstracts. Full-texts of 133 publications were reviewed of which,
112 were excluded resulting in 21 studies included in the review
[11,15,17,21–40]. The selection process is outlined in Fig. 1. Rea-
sons for exclusions of publications were: No description of LVCPFig. 1. Flow diagram oafter PDA surgery (n = 84), and/or less than 80% extremely prema-
ture infants or no subgroup of extremely premature infants
described (n = 22), no PDA surgery (n = 2), not appropriate study
design (n = 2), duplicate (n = 1) or chapter in book (n = 1). Reasons
for exclusions are detailed in Supplemental File 6.Study characteristics
Descriptions of study characteristics including study-
population, exposure, diagnostic method and outcomes are pro-
vided in Table 1. The majority of study designs were cohort studies
(n = 20), and one [23] was a case–control study.REF 23 here 17
studies were retrospective and four were prospective. Seven stud-
ies [11,15,17,23,33,35,37] aimed at measuring the incidence of
LVCP following PDA ligation, and seven studies
[15,22,23,32,33,35,37] at detecting risk-factors/co-morbidities or
outcomes following LVCP after PDA ligation. Half of the included
studies [21,24,25,27–30,34,39,40] did not report or reported
unclearly how LVCP was assessed. Specifically, six studies
[15,17,22,32,36,41] assessed via laryngoscopy only symptomatic
infants, examining laryngoscopically all infants after PDA ligation
[11,23,33,35,37].
The pooled mean GA at birth between the 21 included studies
was 25.6 (range of means 24.5–27.1) weeks and the pooled mean
BWwas 816.5 (range of means 679–1040) g. The pooled mean sur-
gical age of the 12 studies reporting this was 22.0 (range of means
12–57) days. The pooled mean surgical weight of the 8 studies
reporting it was 933.1 (range of means 722–1404) g. There were
8 studies that included a higher maximum GA/BW range. However,
all of these included more than 90% extremely premature infants
[24,29,34,41] and/or a described subgroup of extremely premature
infants [11,17,23,36] and therefore, were used in our analyses.
Six studies [11,15,17,22,23,35] compared GA and BW in children
with and without LVCP. Only five of these [11,15,22,23,35] were
included in this meta-analysis (Figs. 2 and 3), as one study [17]
did not report variations from the mean. Infants with LVCP had
1.2 weeks (95% CI 2.01, 0.39, I2: 70.4%, p = 0.009) lower GA,
and 175.5 g (95% CI 321.5, 29.6; I2: 82.7%, p < 0.001) lower BW.f study selection.
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All ELBW infants with PDA.
1: No treatment (N = 54): GA, 25.7 ± 1.9 wk; BW, 729.6 ± 169.6 g
2: Indomethacin (N = 82): GA, 26.3 ± 1.9 wk; BW, 758.2 ± 139.4 g
3: Primary surgery (N = 46): GA, 24.8 ± 1.5 wk; BW 678.7 ± 153.5 g
4: Indomethacin + surgery (N = 58): GA: 25.7 ± 1.8 wk; BW, 724.4 ±
139.7 g




All ELBW infants, all PDA ligated.
+LVCP (N = 22): GA, 24.5 ± 1 wk; BW, 722 ± 122 g; SA, 17 ± 8.7 d;
SW, 722 ± 140 g.
LVCP (N = 33): GA, 24.8 ± 1.3 wk; BW, 728 ± 132 g; SA, 22 ± 14.5 d;














ELBW (N = 18) and VLBW (N = 5) infants, all PDA ligated.
All LVCP was EP.
+LVCP (N = 12): GA, 24.8 (24–26 wk); BW 725 (580–887 g);
SA, 14.5 (6–31 d)
LVCP (N = 11): GA, 27 (25–31 wk); BW, 1040 (700–1540 g);
SA, 13.8 (4–53 d)
Laryngoscopy
(N = 20/23)
12/18 (67%) Tube feeding, gastrostomy,
hospital stay, readmission,
ventilator support, supplemental




ELBW infants (N = 27/30). All infants (N = 30) were PDA ligated.
GA, 27 (23–34 wk); BW, 811 (650–1620 g)




ELBW infants (N = 125), all PDA ligated. GA, 26 (IQR 25–27 wk);
BW, 840 (IQR 730–1035 g)




EP infants (N = 94/100), 99/100 PDA ligated. GA: 25.6 (23–31 wk);







ELBW infants (N = 95/98)*, all PDA ligated. GA, 26 ± 2wk;
BW, 923 ± 394 g; SA, 29 ± 3 wk; SW, 1222 ± 506 g




ELBW infants (N = 120), all PDA ligated.
Early ligation (N = 75): GA, 25 (22–28 wk); BW, 765 (607–923 g);
SA, 12 (6–20 d); SW, 756 (646–900 g)
Late ligation (N = 45): GA, 24.6 (22–27 wk); BW, 773 (620–901 g);
SA, 30 (24–30 d); SW, 833 (690–990 g)




EP infants (N = 85/92), all PDA ligated.
GA, 25 (23–36 wk); BW, 721 (462–2420 g); SA, 34 (10–94 d);
SW, 1005 (627–3080 g)




VLBW/ELBW infants (N = 94), all PDA ligated.
GA, 26wk+3d ± 2 wk+1 d; BW: 869 ± 223 g




ELBW infants (N = 145), all PDA ligated.
GA, 25.5 ± 2.3 (24–36 wk); BW, 837.7 ± 277.2 (450–1000 g)
SA, 14.1 ± 1.8 d; SW, 881.3 ± 338.1 g




EP infants (N = 82), all PDA ligated.
GA, 25.5 (23–28 wk); BW, 765 (484–1150 g); SA, 21 (5–58 d)




532 infants were PDA ligated. 66 were included in further analysis.
+LVCP (N = 66): GA, 24.75 ± 1.6 wk; BW, 704.2 ± 185.6 g;
SA, 18.4 ± 13.9 d
Laryngoscopy
(N = 66/532)
66/532 (12.4%) Stridor, dysphonia, tube feeding,
bronchopulmonary dysplasia,






Premature infants (N = 100), all PDA ligated.
GA, 25 wk; BW, 740 g; SA, 23 d; SW, 914 g
Laryngoscopy
(N = 61/100)
7/61 (11.5%) Stridor, feeding difficulty,




ELBW infants (N = 82), all PDA ligated.
GA, 2.7 ± 1.74 (23–32 wk); BW, 756 ± 135 (420–1000 g)





EP infants with PDA.
PDA-ligated (N = 13): SA, 12 (4–29 d)
+LVCP (N = 7): GA, 27.1 ± 1.5 wk; BW, 874 ± 138 g
LVCP (N = 4): GA, 27.0 ± 2.9 wk; BW, 982 ± 283 g
No surgery (N = 33): GA, 27.5 ± 1.4 wk; BW, 1051 ± 178 g
Laryngoscopy
(N = 11/13)
7/11 (64%) Ventilator treatment, oxygen
treatment, measures of lung
function, peak heart frequency,
blood pressure, wheezing, severe




EP infants (N = 111), all PDA ligated.
Results presented as mean (95% CI)
+LVCP (N = 19): GA, 25.4 (24.8–26.0 wk); BW, 743.8 (665.4–822.1
g); SA, 22.7 (16.3–29.1 d); SW, 845.8 (766.5–925.2 g)
LVCP (N = 92): GA, 26.7 (26.0–27.5 wk); BW, 990 (858.4–1121.5
g); SA, 52.7 (23.8–81.6 d); SW, 1404 (966.3–1843.4 g)
Laryngoscopy
(31/111)
19/111 (17.1%) Gastroesophageal reflux
syndrome, sepsis,
bronchopulmonary dysplasia,
gastric feeding tube, pneumonia,
anemia of prematurity
(continued on next page)













EP infants (N = 60/86), all PDA ligated. All LVCP were <28 wk GA.
+LVCP (N = 14): GA, 25.4 ± 1.2 wk; BW, 829 ± 205 g; SA, 27 ± 1.3 wk;
SW, 911 ± 181 g
LVCP (N = 72): GA, 26. 9 ± 2.6 wk; BW, 1033 ± 414 g; SA, 29 ± 3.3
wk; SW, 1211 ± 449 g
Laryngoscopy
(N = 86/89)




ELBW infants (N = 55/105), all PDA ligated. All cases of LVCP were
EP. Results presented in median (mean absolute deviation)
Suture: GA, 25.0 ± 2.0 wk; BW, 740 ± 288 g; SW, 1054 ± 626 g
Clip: GA, 24.7 ± 1.3 wk; BW, 561 ± 169 g; SW, 762 ± 210 g
Laryngoscopy
(N = 68/105)
13/55 (23.6%) Hoarseness/stridor, aspiration,





EP infants (N = 31/46), all PDA ligated.
*3/3 infants with LVCP was EP
Total: GA, 26 wk+6,5d (23+6–34 wk+0 d); BW, 943.5 (535–1793 g)









ELBW infants (N = 22/68), all PDA ligated. 5/22 with LVCP was EP.
+LVCP (N = 6): GA, 26.3 wk; BW, 900 g




Results given in mean ± standard deviation and/or range unless other is specified. GA; gestational age, BW; birth weight, SA; age at surgery, SW; weight at surgery. LVCP; left
vocal cord paralysis, EP; extremely premature (1000 g/28 weeks), ELBW; extremely low birth weight (<1000 g), VLBW; very low birth weight (<1500 g), LBW: Low birth
weight (<2500 g), Wk; weeks, g; gram, IVH; intraventricular hemorrhage, NR; not reported.
§ Analysis of incidence of LVCP was performed based on a described subgroup of extremely premature children.
* Additional information provided by author of the publication.
Fig. 2. Gestational age (weeks), weighted mean difference between infants with and without LVCP.
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Twenty-one studies involving 2067 infants were included in
analysis of the incidence of LVCP after PDA surgery (Fig. 4). Five
studies [11,17,23,36,37], calculated the incidence of LVCP in a sub-
group of extremely premature infants, not among all infants who
underwent PDA ligation in the study. Reported incidence of LVCP
ranged from 0% to 67% in the individual studies. The overall pooled
incidence summary estimate was 9.0% (95% CI 5.0, 15.0%). How-
ever, significant heterogeneity was present with an I2 of 91.9%
and Q p-value <0.01. No visual evidence was noted by visualinspection of the funnel plot, and the Egger’s test (p = 0.26) also
suggested that no publication bias was present.
Subgroup analyses
As shown in Fig. 5, heterogeneity decreased, and pooled reports
of LVCP were impacted after stratifying by type of LVCP identifica-
tion method The weighted pooled proportion of LVCP incidence
was 2% (95% CI 0, 4%, I2 = 72.2%, Q-p < 0.01) in studies not reporting
or reporting unclearly how infants with LVCP after PDA ligation
were evaluated [21,24,25,27–30,34,39,40]. The pooled incidence
Fig. 3. Birth weight (g), weighted mean difference between infants with and without LVCP.
Fig. 4. Individual study and overall incidence of LVCP following patent ductus arteriosus surgery. ES; effect size.
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Fig. 5. Overall Incidence of LVCP, stratified by type of assessment method. ES; effect size.
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symptomatic infants via laryngoscopy [15,17,22,32,36,41], and 32%
(95% CI 16, 50%, I2: 84.04%, Q-p < 0.01) in studies assessing all
infants via laryngoscopy [11,23,33,35,37]. After the latter were
stratified by retrospective (n = 31) [23,35] vs. prospective design
(n = 215) [11,33,37] (Fig. 6), the heterogeneity decreased substan-
tially in the retrospective studies (I2: 48.94%, Q-p = 0.14; prospec-
tive studies I2 was 74.47%, Q-p = 0.05). Retrospective studies had
a higher pooled incidence of LVCP of 61.0% (95% CI 43, 78%) com-
pared to prospective studies (19.0%, 95% CI 11, 28%). Heterogeneity
was not reduced by stratification based on PDA surgical closure
method (clip or suture, I2 > 88%).Analysis of reported comorbidities and/or consequences of LVCP
Eight of the 21 included studies reported consequences and/or
comorbidities following LVCP after PDA ligation in extremely pre-
mature infants [11,15,17,22,23,33,35,37]. Six of these studies
[11,15,22,23,35,37] were included in the meta-analysis because
two lacked comparison group. Fig. 7 illustrates the consequences
and/or comorbidities of LVCP following PDA ligation reported by
two or more studies. Bronchopulmonary dysplasia (BPD) was
reported by four studies [15,22,23,35] including 235 infants. The
risk for BPD among premature infants with LVCP was increased;
risk ratio (RR) = 1.60 (95% CI 1.29, 1.99, I2: 0.0%, Q-p = 0.58). The
need of enteral feeding via nasogastric tube or gastrostomy was
reported in three studies [15,22,23] including 189 patients. Thisrisk was strong in premature infants with LVCP although imprecise
due to small sample sizes (RR = 5.76 (95% CI 2.15, 15.46, I2 = 0.0%,
Q-p = 0.40). Two studies [11,37] including 115 patients reported
stridor, and this risk was elevated (RR = 5.22 (95% CI 1.97, 13.86,
I2 = 20.2%, Q-p = 0.26) but imprecise. Asthma or reactive airway
disease was reported by two studies [22,35] including 99 patients,
and the risk of asthma was strong (RR = 2.45 (95% CI 1.52, 3.92, I2 =
0.0%, Q-p = 0.58) and precise. The risk of aspiration, gastroe-
sophageal reflux/gastroesophageal reflux syndrome or intraven-
tricular hemorrhage were all reported by two or three studies
[15,22,23] and included in the meta-analysis, but the pooled risks
between individual studies were not statistically significant. Three
studies [22,23,35] including 89 infants reported differences in total
days spent on mechanical ventilation between infants with and
without LVCP (Fig. 8). Infants with LVCP spent on average 16.5
days (95% CI: 8.57, 24.07, I2 = 58.6%, p = 0.089) longer on mechan-
ical ventilation.Additional analysis
Additional pooling of data was not performed because of the 21
included studies had non-uniform reporting of data among or less
than two studies reported a given outcome. For example, only one
study followed children beyond the age of ten years. Data from
additional analyses are presented in Table 2. Significant differences
between subjects with and without LVCP as regards neonatal out-
comes were reported for neonatal sepsis [15], initial length of hos-
Fig. 6. Overall incidence of LVCP among studies routinely assessing patients with laryngoscopy. ES; effect size.
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sophageal reflux disease surgery [22]. One study [35] reported
follow-up data after discharge and found significantly more airway
obstruction as measured by spirometry in the LVCP group.
Quality assessment
Assessment of quality in the included studies is summarized in
Supplemental File 7. Seventeen studies (81%) scored 4 out of 9 pos-
sible stars. Two studies [21,35] had a control group of extremely
premature infants with PDA who did not undergo PDA ligation,
and scored three additional stars (7/9) for selection and compara-
bility. The only study [11] earning a star for assessment of outcome
examined 97% of infants with laryngoscopy postoperatively. One
study [37] scored only three stars, because 35% of patients were
lost to follow-up and not accounted for. No studies examined
infants for LVCP preoperatively and therefore, all studies missed
a potential star for demonstrating that the outcome of interest
was not present at the start of the study.
Discussion
The overall pooled incidence of LVCP after PDA ligation in extre-
mely premature children was 9.0%. However, the incidence varied
widely (0–67%) between studies. Higher incidence was seen in
studies that examined all children with laryngoscopy after ligation
(32%), and in studies with a retrospective design (61%) compared
to those with a prospective design (19%). Results revealed a scar-
city of follow-up studies that could provide further knowledge
on short- and long-term outcomes. However, based on analyses
of the available outcome data, we found that infants with LVCP,
overall, had a significantly higher risk of negative outcomes. Fur-
ther prospective research analyzing confounding factors is needed.To our knowledge, this is the first systematic review that
focused on identifying the incidence of LVCP after PDA ligation in
extremely premature infants. A strength of this study is that the
aim and search strategy were restricted to one type of cardiotho-
racic surgery and we only included studies describing extremely
premature infants. Thus, our search strategy was more specific
compared to a previous systematic review [16] on LVCP that
included various types of cardiothoracic surgery in infants and
children. In addition, we had no language restrictions, and our
search identified new research on the topic.
Low gestational age, low birth weight and lowweight at surgery
are known risk factors for LVCP [11,15,17]. Therefore, we expected
a high LVCP pooled incidence in this research as we only included
studies describing extremely premature infants. However, our
overall LVCP pooled incidence is similar (9.0% vs 8.7%) to that
reported by Strychowsky et al. [16], in a sub-analysis of 21 studies
investigating incidence of LVCP after PDA ligation in infants and
children. Congruent results between these two meta-analyses
could be due to the expectedly high proportion of extremely pre-
mature infants in studies investigating consequences of surgical
PDA ligation. Of note, about half of the studies included by Stry-
chowsky et al. [16,11,15,17,22,23,25,33,35–37,40] (n = 11) were
also included in our meta-analysis.
LVCP assessment methods could partly explain the large
between-studies variability in the reported incidence of LVCP
[16]. For example, our results showed that the incidence of LVCP
was substantially higher in studies routinely assessing all infants
postoperatively via laryngoscopy (32%), compared to those that
performed laryngoscopy only in symptomatic infants (16%). The
pooled incidence of LVCP was only 1% in studies with unclear or
unreported vocal cord assessment method. Strychowsky et al.
[16] found a weighted pooled proportion for LVCP of 39% in studies
that assessed infants and children by laryngoscopy after PDA liga-
Fig. 7. Individual studies and overall risk of consequences and/or comorbidities of LVCP.
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ky’s analysis were included in our analysis, congruent results are
not surprising. We chose to exclude one study [22] from our sub
analysis because only symptomatic infants were examined via
laryngoscopy. This exclusion contributed to a slightly lower
weighted pooled proportion of LVCP in our study (32% vs. 39%).
This variability in reported incidence may be due to the transient
nature of LVCP symptoms in infants. It seems clear that the meth-
ods of assessment significantly impact incidence reports, and that
LVCP may be undetected unless routinely looked for via laryn-
goscopy [11,32,33,38,42]. In addition, some infants presenting
with typical symptoms of LVCP, such as stridor and dysphonia,
may not have LVCP when examined via laryngoscopy [11,22,37].
This stresses the point that symptom-based diagnosis of LVCP is
not reliable, may cause misleading rates of postoperative LVCP
incidence and also may lead to misdiagnoses and erroneous man-
agement of these infants.
Preoperative laryngoscopy was not performed in all but one
study [15]. Considering that extremely premature infants referredto PDA surgery are critically ill and may require intubation before
surgery [15,43,44], preoperative laryngoscopy may be difficult and
unethical to perform [43,44]. Lack of preoperative assessment of
the vocal cords may confuse the postoperative LVCP incidence
rates, as other potential causes of LVCP among infants exists. For
example, cases of idiopathic or neurological causes of LVCP have
been reported among neonates [9,10,44]. Moreover, a large PDA
can possibly compress the left recurrent laryngeal nerve and lead
to injury [45]. In addition, findings of vocal cord paralysis would
have been equally distributed between the right and left side
should intubation have caused direct injury to the vocal cord. How-
ever, this was not the case in any of the included studies. Theoret-
ically, one may speculate that a partial preoperative paralysis of
the left recurrent laryngeal nerve due to a large pulsating PDA, or
a partial paralysis of the left recurrent laryngeal nerve due to peri-
operative traction on the nerve, may lead to a transient immobi-
lization of the left side of the larynx, and thus predispose the left
side of the larynx to postoperative intubation trauma. However,
this needs to be addressed in properly designed studies.
Fig. 8. Duration of ventilation (total number of days). Weighted mean difference between infants with and without LVCP.
Table 2
Additional analysis.
Study Outcomes LVCP No LVCP p-Value
Respiratory outcomes
Spanos, 2009 Episodes of decreased O2-saturation, N (%) 2/13 (15) 4/54 (7) 0.48
Roksund, 2010 Forced expiratory volume (FEV1),
% of predicted
71.9% 83.3% <0.05*
Roksund, 2010 Flow through middle half of forced vital capacity, % of predicted 51% 83% <0.05*
Roksund, 2010 Peak expiratory flow, % of predicted, mean (95% CI) 76.4 (63–90) 102.5 (92–113) >0.05
Roksund, 2010 Forced vital capacity, % of predicted, mean (95% CI) 99.1 (85–113) 98.0 (83–113) >0.05
Roksund, 2010 Maximal oxygen uptake, % of reference, mean (95% CI) 96.2 (83–110) 96.3 (72–121) >0.05
Laryngeal outcomes
Roksund, 2010 Dysphonia, N (%) 6/7 (85.7) 1/4 (25.0) 0.07
Smith, 2009 Dysphonia, N (%) 9/14 (20.5) 8/72 (11) <0.001*
Spanos, 2009 Dysphonia, N (%) 9/13 (69) 9/54 (17) <0.001*
Nichols, 2014 Dysphonia, N (%) 51/66 (77.3) –
Nichols, 2014 Laryngomalacia, N (%) 26/66 (38) –
Nichols, 2014 Subglottic stenosis, N (%) 3/66 (5) –
Feeding outcomes
Benjamin, 2010 Nissen fundoplication, N (%) 9/22 (41) 1/33 (3) 0.001*
Other outcomes
Benjamin, 2010 Hospital stay (total days) 148.2 96.8 <0.001*
Benjamin, 2010 Neurodevelopmental IMPAIRMENT (18–22 months) 10/22 (56) 8/11 (36) 0.34
Benjamin, 2010 Intraventricular hemorrhage
(grade 3 or 4), N (%)
8/22 (36) 4/33 (12) 0.05
Clement, 2008 Readmission within 12 months, N (%) 6/12 (50) 2/11 (18) 0.19
Nichols, 2014 Retinopathy of prematurity, N (%) 50/62 (81) –
Rukholm, 2012 Retinopathy of prematurity, N (%) 8/19 (42.1) 22/92 (23.3) 0.154
Rukholm, 2012 Sepsis, N (%) 14/19 (73.7) 36/92 (39.1) 0.010*





* Marks significant difference (p < 0.05) between groups as reported in individual publications. Two exceptions are p-values for Dysphonia from Smith et al. (2009) and
Roksund et al. (2010), as these values were calculated based on Odds Ratios by authors of this Systematical Review.
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between study variability in reported LVCP incidence. The three
prospective studies [11,33,37] included in our analysis had a sub-
stantially lower incidence of LVCP compared to the two retrospec-tive studies [23,35]. A possible explanation for this could be due to
the fact that surgeons participating in prospective studies may be
more cognizant of the risk of recurrent laryngeal nerve damage
and therefore, more cautious during surgery. However, Carpes
84 M.S. Engeseth et al. / Paediatric Respiratory Reviews 27 (2018) 74–85et al. [44] described a higher odd of damaging the recurrent laryn-
geal nerve upon visualization of the nerve during surgery. This
observation could imply that the laryngeal nerve is vulnerable to
low impact trauma such as traction, and that efforts made to avoid
damaging to the nerve could actually be harmful.
We found that a range of adverse outcomes or comorbidities
were associated with LVCP. As several studies [23,32,33,37,38]
have reported low rates (0–33%) of recovery, infants are thus left
with a potential for life-long sequelae. Undetected LVCP that is
confused with other medical conditions could theoretically lead
to inappropriate and potentially harmful treatment choices. Infants
with LVCP can present with symptoms such as apneas or increased
work of breathing associated with stridor. Such symptoms might
leave infants susceptible for prolonged hospital stay, and pro-
longed and possibly unnecessary mechanical ventilation in the
misbelief that they suffer from lung disease [22,23,33,35]. In turn,
such unnecessary treatment can complicate subsequent handling
of the baby and also lead to acute and chronic pulmonary prob-
lems, e.g., BPD [43,46]. Early LVCP detection could theoretically
allow use of less invasive ventilatory support, such as CPAP, and
thus facilitate better airflow despite laryngeal obstruction.
In older children symptoms of LVCP have been confused with
symptoms of asthma [35]. These children have been treated with
medications instead of receiving treatment for their actual condi-
tion. Therefore, we propose that laryngoscopy should be performed
before hospital discharge in infants who have undergone surgical
PDA ligation.
Benefits versus disadvantages of surgical ligation of PDA have
been debated in recent years [6,47–50]. Surgical ligation has been
associated with a range of morbidities [11,23,51–54]. Extremely
premature infants undergoing surgical PDA ligation are often the
most vulnerable and at risk of a range of morbidities [55]. We
can hardly study the consequences of PDA surgery and LVCP with-
out facing the problem of selection bias or confounding by surgical
indication as infants selected for surgical ligation may have a
higher baseline risk for comorbidities [50]. We suggest that future
studies prospectively enroll extremely premature infants undergo-
ing PDA ligation and explore possible short and long-term conse-
quences of LVCP. Future studies should also perform routinely
pre- and postoperative laryngoscopy examinations, use matched
controls, and try to control for selection bias.Study limitations
Our study has several strengths including an exhaustive search,
a rigorous protocol driven approach, and meta-analytical analyses
of potentially important subgroups. The major limitation of this
study, similar to many meta-analyses, lies in the data on which it
was based; i.e., the wide heterogeneity and the varying approach
between the included studies. However, we were able to explain
some of this heterogeneity that could also be utilized to speculate
over issues of clinical interest.Conclusion
The pooled incidence of LVCP after PDA ligation in extremely
premature infants was 9%, with a wide heterogeneity depending
on the method used for LVCP assessment and study design. Unfor-
tunately, routine laryngoscopy is rarely performed in relation to
PDA ligation, preventing identification of all cases of PDA-related
LVCP. A range of adverse outcomes and/or comorbidities were
found to be associated with LVCP; however, the full picture of this
still remains unknown due to lack of systematic follow-up studies.Early recognition of LVCP seems to be of significant clinical value,
which supports routine laryngoscopy performed after PDA ligation.Funding source
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Directions for future research
 Prospective multi-center cohort study including all infant born
preterm undergoing PDA surgical closure to determine the inci-
dence and risk factors of LVCP.
 Investigate the mechanisms of injury that leads to LVCP in
infants born preterm exposed to surgical closure of PDA.
 Investigate clinical symptoms and outcomes of LVCP after surgi-
cal closure of PDA in infants born preterm with, both during
their NICU hospitalization and later in life.
 Develop therapies aimed at alleviating symptoms and restoring
laryngeal function in ex-preterm children with LVCP after surgi-
cal closure of PDA.
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